• Report Number: 5009
  • Publish Date: 24-May-2018

Reports Overview

Chlorhexidine gluconate solution is a topical antibiotic used for multiple external applications. It is an aqueous solution of chlorhexidine gluconate. It contains NLT 19.0% and NMT 21.0% of chlorhexidine gluconate.

Rise in number of surgical procedures with rise in prevalence & incidence of various chronic diseases, and increase in aging population drive the demand for chlorhexidine gluconate solution. Unexpected fluctuations in raw materials prices restrict the market growth. In addition, stringent government regulations associated with the usage of chemicals hamper the market growth during the forecast period.

The report segments the chlorhexidine gluconate solution market on the basis of application and geography. Based on application, it is divided into preoperative skin preparation, surgical hand scrub, healthcare personnel hand hygiene and skin wound & general skin cleanser. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as H&R Healthcare Ltd., Cadila Pharmaceuticals Ltd., Basic Pharma Life Science Pvt. Ltd., PSK Pharma Pvt. Ltd., Proton Pharma Private Limited, Abhilasha Pharma Pvt. Ltd., Neelkanth Healthcare Pvt. Ltd., Afton Pharma, Glide Chem Private Limited, and Sceptre Medical India Private Limited is also provided in the report.

Key Benefits

  • This report provides a quantitative analysis of the current trends and estimations from 2017 to 2023 of the global chlorhexidine gluconate solution market to identify the prevailing market opportunities.
  • Major countries in each region are mapped according to individual market revenue.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • An in-depth analysis of current research & clinical developments within the market is provided with key dynamic factors.
  • Key players and their key developments in the recent years are listed.

Chlorhexidine Gluconate Solution Market Key Segments:

By Application

  • Preoperative Skin Preparation
  • Surgical Hand Scrub
  • Healthcare Personnel Hand Hygiene
  • Skin Wound & General Skin Cleanser

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Argentina
    • Turkey
    • Rest of LAMEA

Other Market Players

  • Dwarkesh Pharmaceuticals Pvt. Ltd.
  • Microlab Limited
  • Intas Pharmaceuticals Ltd
  • Lupin Ltd.
  • Cipla Ltd.
  • Wockhardt Ltd.
  • Sun Pharma Ltd.
  • Hicks Themometer (India) Ltd
  • Dev Life Corporation
  • Cian Healthcare Private Limited
  • Cardinal Health
  • R. N. Laboratories Pvt. Ltd.

Table of Content

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GLOBAL CHLORHEXIDINE GLUCONATE SOLUTION MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PREOPERATIVE SKIN PREPARATION

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SURGICAL HAND SCRUB

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. HEALTHCARE PERSONNEL HAND HYGIENE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. SKIN WOUND & GENERAL SKIN CLEANSER

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5 GLOBAL CHLORHEXIDINE GLUCONATE SOLUTION MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. By Application

5.2.4. U.S.

5.2.4.1. Market size and forecast, by Application

5.2.5. Canada

5.2.5.1. Market size and forecast, by Application

5.2.6. Mexico

5.2.6.1. Market size and forecast, by Application

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. By Application

5.3.4. Germany

5.3.4.1. Market size and forecast, by Application

5.3.5. France

5.3.5.1. Market size and forecast, by Application

5.3.6. UK

5.3.6.1. Market size and forecast, by Application

5.3.7. Italy

5.3.7.1. Market size and forecast, by Application

5.3.8. Rest of Europe

5.3.8.1. Market size and forecast, by Application

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. By Application

5.4.4. China

5.4.4.1. Market size and forecast, by Application

5.4.5. Japan

5.4.5.1. Market size and forecast, by Application

5.4.6. India

5.4.6.1. Market size and forecast, by Application

5.4.7. Australia

5.4.7.1. Market size and forecast, by Application

5.4.8. Korea

5.4.8.1. Market size and forecast, by Application

5.4.9. Rest of Asia-Pacific

5.4.9.1. Market size and forecast, by Application

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. By Application

5.5.4. Brazil

5.5.4.1. Market size and forecast, by Application

5.5.5. Saudi Arabia

5.5.5.1. Market size and forecast, by Application

5.5.6. South Africa

5.5.6.1. Market size and forecast, by Application

5.5.7. Rest of LAMEA

5.5.7.1. Market size and forecast, by Application

Chapter: 6 COMPANY PROFILES

6.1. H&R HEALTHCARE LTD.

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. CADILA PHARMACEUTICALS LTD.

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. BASIC PHARMA LIFE SCIENCE PVT. LTD.

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. PSK PHARMA PVT. LTD.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. PROTON PHARMA PRIVATE LIMITED

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. ABHILASHA PHARMA PVT. LTD.

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. NEELKANTH HEALTHCARE PVT. LTD.

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. AFTON PHARMA

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. GLIDE CHEM PRIVATE LIMITED

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. SCEPTRE MEDICAL INDIA PRIVATE LIMITED

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments

There are no reviews yet.

Be the first to review “Chlorhexidine Gluconate Solution Market Opportunity Analysis and Industry Forecast 2017-2023”